Tapiwa Ganyani
't Hasselt, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and immunogenicity of an mRNA COVID-19 vaccine administered to adults: A phase 2, randomized, active-controlled trial.
Journal: Human vaccines & immunotherapeutics
Published: August 26, 2026
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
Journal: Human vaccines & immunotherapeutics
Published: October 18, 2024
Authors' response: Estimating the generation interval for COVID-19 based on symptom onset data.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: July 29, 2020
Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: May 07, 2020
Inference of the generalized-growth model via maximum likelihood estimation: A reflection on the impact of overdispersion.
Journal: Journal of theoretical biology
Published: January 29, 2019
Assessing the relationship between epidemic growth scaling and epidemic size: The 2014-16 Ebola epidemic in West Africa.
Journal: Epidemiology and infection
Published: October 16, 2018
Assessing inference of the basic reproduction number in an SIR model incorporating a growth-scaling parameter.
Journal: Statistics in medicine
Published: September 18, 2017
Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness.
Journal: PloS one
Published: August 25, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026